Jun 02,2014

Cartagenia Closes $5.9M (€4.25M) Financing Round

Cartagenia, the leading provider of clinical-grade solutions for genomic assay interpretation and lab reporting to diagnostic genetics labs, clinicians and hospitals, today announced the closing of a $5.9 million (€4.25 million) financing round. The financing was subscribed by Cartagenia's existing shareholders and management. Shareholders include Capricorn ICT Arkiv, a Leuven-based ICT fund focussing on Digital Healthcare and Big Data, the Flemish investment company PMV and Gemma Frisius Fund, the venture fund of the University of Leuve. Cartagenia currently serves more than 120 labs and clinics across North America, Europe and Australia with its Bench Lab™ platform.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 22,2022

Limbo is tackling obesity with a pair of wearables and decades of physiology

Limbo, a New York, London and Cork-based startup which is announcing a $6 million seed raise today, is in this growing pack commercializing CGM tech — in its case building a subscription weight management business to target the obesity crisis.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Jan 01,2019

Changing Health Raises £3 million For New Behaviour Change Programmes

Changing Health, a leading provider of digital behaviour change programmes, has secured £3 million in new funding. The round was led by Shift Invest from the Netherlands, together with renewed investment from existing backers, Tate & Lyle Ventures and the North East Innovation Fund supported by the European Regional Development Fund, and managed by Northstar Ventures.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 28,2019

Digital health company developing minimally invasive CGM Biolinq raises additional $4.75M

This morning Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $4.75 million in extended Series A financing. This new capital was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 26,2019

Omada Health takes in $73M more in new funding round

San Francisco-based digital chronic disease management company Omada Health has closed a $73 million funding round led by Wellington Management Company. Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures also contributed.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Jun 19,2019

Teladoc Health Strategic Investment: Vida Health Raises $30 Million in Series C Funding

Vida Health, a personalized virtual care platform for physical and behavioral health, today announced the close of $30M in Series C investment. Strategic investors include GuideWell Mutual Holding Corporation, Teladoc Health and Workday Ventures.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jun 26,2019

DayTwo, Microbiome Startup for Diabetes, Raises $31M for U.S. Growth

DayTwo has snagged $31 million as it looks to provide nutritional support to the 30 million people living with type 2 diabetes across the United States.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 16,2019

Smartphone-connected glucometer Pops! Diabetes Care rakes in $6M

Diabetes management startup Pops! Diabetes Care has scored $6 million in an oversubscribed Series A round. The round was led by 30Ventures with participation from Rise of the Rest Seed Fund and Flying Point Industries.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 31,2019

Hello Heart collects $12M for digital chronic disease management

Hello Heart, maker of a digital chronic disease health program for employees, has raised $12 million in Series B funding. The round was led by Khosla Ventures, with additional support from previous backers BlueRun Ventures, Maven Ventures and Resolute Ventures. The company also branched out into diabetes management in 2018, adding blood sugar tracking tools alongside new personalized prompts designed to drive healthy behavior change

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 01,2019

Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced an $8 million (USD) senior credit facility from existing major shareholders, with the first $3.5 million available immediately, to help fund the Company’s European commercial launch plans. The non-dilutive credit facility will carry 8% interest with quarterly payments and the principal due only upon maturity in 5 years. The credit facility has no stock, warrants, or equity related instruments, or other associated expenses.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING